Personalized Medical Devices (PMD)

Working Group Chair(s)
Tracey Duffy
Therapeutic Goods Administration (TGA)
Australia
Membership
Regulators, Regional Harmonization Initiatives, Official Observers
Status
Current

Advances in materials science, computational power, imaging and manufacturing technologies have made it possible to produce medical devices that are designed to meet the specific needs of a particular individual (i.e. personalized medical devices or PMDs). The manufacturing processes for PMDs is also shifting closer to the point-of-care (such as 3D printing in hospitals), which brings numerous advantages to patients and healthcare professionals. However, new risks have also emerged with PMDs and point-of-care manufacturing, which did not exist for traditional mass-produced medical devices.

The purpose of this Work Item is to develop guidance documents for providing harmonized recommendations for the regulation of PMDs. The adoption of consistent and harmonized requirements for PMDs across various jurisdictions will offer significant benefits to users, patients, manufacturers, and regulatory authorities.

The Working Group have published updated IMDRF Technical Documents to provide recommendations for production validation of PMDs including technical guidance on:

  • Validation of the specified design envelope that is one of the defining features of a patient-matched medical device
  • Validation of a Medical Device Production System (a relatively new framework for regulating point-of-care manufacture of PMDs.
Technical/Informational document

Participants

Adriana David
National Administration of Drugs, Food and Medical Devices (ANMAT)
Verónica Tarcaya
National Administration of Drugs, Food and Medical Devices (ANMAT)

Uphar Chamoli
Therapeutic Goods Administration (TGA)
Zoe Barrand
Therapeutic Goods Administration (TGA)

Adriano Soares da Silva
Brazilian Health Regulatory Agency (ANVISA)
Joao Henrique Campos de Souza
Brazilian Health Regulatory Agency (ANVISA)
Maria Angela da Paz
Brazilian Health Regulatory Agency (ANVISA)

Andrea Katynski
Health Canada

Shuo Pan
Center for Medical Device Evaluation (CMDE), NMPA
Yue Min
Center for Medical Device Evaluation (CMDE), NMPA

Mario Ernesto Vega Valenzuela
Sanitary Regulation Superintendency (SRS)

Mariana Isabel Vaz Afonso Pires Madureira
National Security Agency of Medicines and Health Products - Portugal
Matthias Neumann
German Federal Ministry of Health
Nada Alkhayat
European Commission
Stefan De Vos
Belgian National Competent Authority for Medical Devices

Abdullatif Al Watban
Saudi Food and Drug Authority

Momoka Sasajima
Pharmaceuticals and Medical Devices Agency (PMDA)
Ryosuke Morita
Pharmaceuticals and Medical Devices Agency (PMDA)
Takashi Ooba
Ministry of Health, Labour and Welfare (MHLW)
Tomohiko Makino
Ministry of Health, Labour and Welfare (MHLW)

Konstantin Ivanov
Federal Service for Surveillance in Healthcare (Roszdravnadzor)

Shuling Peng
Health Sciences Authority (HSA)

Si Hyung Yoo
Ministry of Food and Drug Safety (MFDS)
Yunju Lee
Ministry of Food and Drug Safety (MFDS)

Dr. Te-Hsuen Chen
Taiwan Food and Drug Administration (TFDA)

Kanika Darbar
Medicines and Healthcare products Regulatory Agency (MHRA)

Erin Keith
Food and Drug Administration (US FDA)
Matthew Di Prima
Food and Drug Administration (US FDA)